Information Provided By: 
Fly News Breaks for August 26, 2016
MDT
Aug 26, 2016 | 07:13 EDT
After Medtronic reported higher than expected Q1 EPS and in-line revenue, Piper Jaffray analyst Brooks West says the quarter was "just fine." He says that the company's failure to raise its revenue guidance to reflect recent acquisitions was conservative and "de-risks" its now "beatable" guidance. West expects new products to bolster the company's revenue, and he predicts that it will continue to gain share in CRM. He keeps a $104 price target and Overweight rating on the stock.
News For MDT From the Last 2 Days
